Use this URL to cite or link to this record in EThOS:
Title: Characterisation of TPL-2 signalling pathways in innate immunity
Author: Mitchell, O.
ISNI:       0000 0004 7659 8467
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2015
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
The MAP 3-kinase TPL-2 is required for activation of ERK1/2 MAP kinases in macrophages after stimulation of Toll-like receptors and the receptors for TNF and IL-1β. TPL-2 drives inflammation in a number of autoimmune and inflammatory disease models, and consequently is considered a potential anti-inflammatory drug target. Recent evidence from the Ley laboratory has indicated that TPL-2 regulates the production of the critical pro-inflammatory cytokine TNFα in an ERK1/2-independent manner. The aim of this study was to use mass spectrometry-based phosphoproteomics to investigate the signalling pathways regulated by TPL-2 in an unbiased manner to more fully understand how TPL-2 regulates innate immunity. A method for SILAC labelling of bone marrow-derived macrophages was developed and used to quantify phosphorylation changes after genetic and pharmacological perturbation of TPL-2 signalling. Across 11 pair-wise comparisons, 31,457 unique phosphosites were identified, from which a shortlist of 37 potentially TPL-2-dependent, ERK1/2-independent phosphorylations was generated. The biological consequences of the majority of these TPL-2 regulated sites remain to be determined, although bioinformatic analysis suggest that they may have roles in regulation of gene expression and the cytoskeleton. The activating residues of the MAP 2-kinases, MKK3 and MKK6 were validated as novel TPL-2 targets in LPS-stimulated macrophages and MKK6 was shown to be a direct substrate by in vitro kinase assays using recombinant proteins. It was also demonstrated that TPL-2 controlled the phosphorylation of the activation loop of the MAP kinase p38γ, which is a direct target of MKK3/6. These data identified a novel signalling pathway downstream of TPL-2, increasing our understanding of how TPL-2 controls inflammatory responses.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available